Recent Advances in Process Development of Antiviral Agents Targeting the Influenza Virus: Amantadine-RemantadineDerived Pharmaceutical Agents

Journal Title: Open Access Journal of Pharmaceutical Research - Year 2018, Vol 2, Issue 2

Abstract

This short review summarizes our work on the process development for the synthesis of amontidine remantadine. The M2 proton channel of the influenza A virus is the target of the anti-influenza drugs amantadine and rimantadine. The effectiveness of these drugs has been dramatically limited by the rapid spread of drug resistant mutations, mainly at sites S31N, V27A and L26F in the pore of the channel. Despite progress in designing inhibitors of V27A and L26F M2, there are currently no drugs targeting these mutated channels in clinical trials. The article traces the evolution of various synthesis approaches and provides a comparison for overall yield efficiency. Amantadine hydrochloride is an antiviral drug used in prevention and treatment of influenza a infections. It has also been used for alleviating early symptoms of Parkinson’s disease. Several methods for the preparations of Amantadine hydrochloride have been reported. Overall yields ranging from 50 to 52%. In this article, we describe procedure for the synthesis of Amantadine hydrochloride from via N-(1- adamantyl) acetamide with an improved yield of 60% the procedure was also optimized to reduce the use of toxic solvents and reagents, rendering it more environment-friendly. The procedure can be considered as suitable for largescale production of amantadine hydrochloride.

Authors and Affiliations

Pathy KS*

Keywords

Related Articles

Dementia with Lewy Bodies (DLB): Major Pathological Changes That Result in Major Clinical Features

To describe the major pathological changes that occurs in the brain of a person with dementia with Lewy bodies (DLB) disease. In addition, to also describe the major clinical features that occurs in relation to these pa...

Anti-Inflammatory agents from Mushrooms: A Review

Mushrooms can be highlighted as alternate sources of anti-inflammatory drugs. In recent years, natural resources have come into spotlight due to their enormous potential to be utilized in the discovery/development of no...

Formulation and Evaluation of Co-Processed Excipient

The main purpose of the current review article is to provide a comprehensive overview of the latest developments in assistive technology and the mechanisms involved in the development of those assistants. Architectural...

Virtual Screening and Validation of Potential Lead Compound from the Malaria Box against Plasmodium Falciparum S7 and S19 Proteins

Molecular docking is a computer based tool used in drug design, where predominant binding modes of a ligand with known three dimensional protein structures are predicted. This study addresses the possible ways of coming...

Insights into Mefenamic Acid-Induced Allergic Reactions: A Comprehensive Clinical and Research Review

This study investigates the incidence of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome associated with the over-the-counter non-steroidal anti-inflammatory drug (NSAID) mefenamic acid. Approximately...

Download PDF file
  • EP ID EP745914
  • DOI 10.23880/oajpr-16000155
  • Views 26
  • Downloads 0

How To Cite

Pathy KS* (2018). Recent Advances in Process Development of Antiviral Agents Targeting the Influenza Virus: Amantadine-RemantadineDerived Pharmaceutical Agents. Open Access Journal of Pharmaceutical Research, 2(2), -. https://europub.co.uk/articles/-A-745914